Milestone Alert: More Than 300,000 Patients With Suspicious Lesions Have Been Assessed Using Nevisense May 27, 2025
U.S. FDA Grants Interchangeability Designation to Samsung Bioepis and Organon’s Humira Biosimilar May 27, 2025